| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
solute carrier organic anion transporter family member 6A1 | 0.412 | 0.885 | 2.9E-11 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2004 | 2004 | ||||||||
|
cellular communication network factor 2 | 0.399 | 0.846 | 5.0E-04 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2007 | 2007 | ||||||||
|
cytochrome P450 family 2 subfamily C member 9 | 0.506 | 0.885 | 1.3E-10 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2009 | 2009 | ||||||||
|
inhibitor of Bruton tyrosine kinase | 0.678 | 0.538 | 2.2E-03 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2018 | 2018 | ||||||||
|
integrin linked kinase | 0.503 | 0.769 | 3.8E-05 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2012 | 2012 | ||||||||
|
glutathione S-transferase kappa 1 | 0.412 | 0.885 | 1.9E-06 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2004 | 2004 | ||||||||
|
proteasome 20S subunit beta 8 | 0.533 | 0.808 | 2.2E-02 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2013 | 2013 | ||||||||
|
proteasome 20S subunit beta 9 | 0.514 | 0.808 | 2.7E-03 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2013 | 2013 | ||||||||
|
proteasome 20S subunit beta 10 | 0.736 | 0.462 | 1.8E-06 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2010 | 2010 | ||||||||
|
proteasome 26S subunit, ATPase 1 | 0.780 | 0.462 | 1.00 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
microRNA 193b | 0.536 | 0.808 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2009 | 2009 | |||||||||
|
selectin L | 0.505 | 0.846 | 5.0E-07 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 1998 | 1998 | ||||||||
|
SRY-box transcription factor 1 | 0.617 | 0.692 | 0.62 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2010 | 2010 | ||||||||
|
TAP binding protein | 0.576 | 0.769 | 6.6E-09 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2010 | 2010 | ||||||||
|
deleted in lymphocytic leukemia 2 | 0.650 | 0.500 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2003 | 2003 | |||||||||
|
cytochrome P450 family 1 subfamily A member 1 | 0.436 | 0.846 | 1.1E-17 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2008 | 2012 | ||||||||
|
nuclear receptor subfamily 0 group B member 1 | 0.494 | 0.808 | 0.97 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2017 | 2019 | ||||||||
|
interleukin 27 | 0.457 | 0.808 | 0.78 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2014 | 2017 | ||||||||
|
glutathione S-transferase mu 1 | 0.380 | 0.923 | 2.1E-03 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2007 | 2008 | ||||||||
|
purinergic receptor P2X 7 | 0.450 | 0.808 | 3.3E-11 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2006 | 2010 | ||||||||
|
interleukin 17D | 0.464 | 0.808 | 0.20 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2014 | 2017 | ||||||||
|
myeloid derived growth factor | 0.451 | 0.846 | 3.5E-06 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2014 | 2017 | ||||||||
|
protein tyrosine kinase 2 | 0.497 | 0.808 | 1.00 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2012 | 2019 | ||||||||
|
spleen associated tyrosine kinase | 0.475 | 0.808 | 1.00 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2005 | 2019 | ||||||||
|
X-ray repair cross complementing 1 | 0.421 | 0.923 | 6.3E-09 |
|
disease | 0.020 | None | 0.500 | 2 | 1 | 2011 | 2019 |